+ Follow PHARMACOECONOMIC Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 221973
[Title] => Price competition benefits patients
[Summary] => And the battle begins. Much like the way cholesterol stiffens the arteries causing heart problems, competition in the local anticholesterol market also stiffens, but in a favorable way for the patients, with multinationals rolling back their prices by as much as 57 percent.
This decision, according to some medical practitioners, is a welcome development in the pharmaceutical industry, which was likely triggered by the introduction of a bioequivalent brand of simvastatin by a local company which was sold at half the price of the innovator product.
[DatePublished] => 2003-09-25 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
PHARMACOECONOMIC
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 221973
[Title] => Price competition benefits patients
[Summary] => And the battle begins. Much like the way cholesterol stiffens the arteries causing heart problems, competition in the local anticholesterol market also stiffens, but in a favorable way for the patients, with multinationals rolling back their prices by as much as 57 percent.
This decision, according to some medical practitioners, is a welcome development in the pharmaceutical industry, which was likely triggered by the introduction of a bioequivalent brand of simvastatin by a local company which was sold at half the price of the innovator product.
[DatePublished] => 2003-09-25 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
abtest
September 25, 2003 - 12:00am